Universe Pharmaceuticals (UPC) Stock Price, News & Analysis

Company Overview

Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.

Key Stats

• Today's Range: $3.24 to $3.63
• 50-Day Range: N/A
• 52-Week Range: $2.51 to $2,418.00
• Volume: 27,039 shs
• Average Volume: 32,335 shs
• Market Capitalization: $130.80 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

UPC Stock Analysis - Frequently Asked Questions

How have UPC shares performed this year?

Universe Pharmaceuticals' stock was trading at $4.67 at the start of the year. Since then, UPC stock has decreased by 30.0% and is now trading at $3.27.

When did Universe Pharmaceuticals IPO?

Universe Pharmaceuticals (UPC) raised $30 million in an initial public offering (IPO) on Tuesday, March 23rd 2021. The company issued 5,000,000 shares at a price of $5.00-$7.00 per share. Univest Securities, LLC acted as the underwriter for the IPO.

How do I buy shares of Universe Pharmaceuticals?

Shares of UPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/20/2025
• Fiscal Year End: 9/30/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:UPC
• CIK: 1809616
• Web: N/A
• Phone: 86-0796-8403309
• Fax: N/A
• Employees: 220
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.04
• Current Ratio: 2.78
• Quick Ratio: 2.62

Sales & Book Value

• Annual Sales: $19.29 million
• Price / Sales: 0.01
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $7,528.62 per share
• Price / Book: 0.00

Miscellaneous

• Outstanding Shares: 43,000
• Free Float: 18,000
• Market Cap: $140.61 thousand
• Optionable: N/A
• Beta: 1.43